Results 161 to 170 of about 6,101 (249)

Rehabilitation improves the effectiveness of nusinersen in children with type 2 spinal muscular atrophy: pNF-H and muscle MRI as potential biomarkers. [PDF]

Front Neurol
Sun Y, Li W, Cui X, Li Y, Gao X, Fu D, Zhao X, Cao T, Zhu M.   +8 more
europepmc   +1 more source

Novel Complication of Nusinersen Treatment: Hyponatremia [PDF]

Journal of Clinical Intensive Care and Medicine, 2018
openaire   +1 more source

Serum creatinine to cystatin C ratio as monitoring biomarker in Chinese adult spinal muscular atrophy: a prospective cohort study. [PDF]

Orphanet J Rare Dis
Chen S, Wang Q, Fu J, Wei Q, Ou R, Lai X, Chen X, Shang H.   +7 more
europepmc   +1 more source

Total Intramuscular Fat Fraction of Thigh Muscles as a Predictor of Nusinersen Efficacy in Pediatric SMA Type II and III. [PDF]

Diagnostics (Basel)
Iketani K, Awano H, Hashimura H, Sonehara S, Hanafusa H, Nambu Y, Nishio H, Nozu K, Bo R.   +8 more
europepmc   +1 more source

Long-term CSF responses in adult patients with spinal muscular atrophy type 2 or 3 on treatment with nusinersen. [PDF]

J Neurol
Cebulla G, Hai L, Warnken U, Güngör C, Hoffmann DC, Korporal-Kuhnke M, Wildemann B, Wick W, Kessler T, Weiler M.   +9 more
europepmc   +1 more source

Functional and structural analysis of SITTER patients with spinal muscular atrophy. [PDF]

Sci Rep
Bieniaszewska A, Sobieska M, Gajewska E.
europepmc   +1 more source

Multi-omics profiling in spinal muscular atrophy (SMA): investigating lipid and metabolic alterations through longitudinal CSF analysis of Nusinersen-treated patients. [PDF]

J Neurol
Zandl-Lang M, Züllig T, Holzer M, Eichmann TO, Darnhofer B, Schwerin-Nagel A, Zobel J, Haidl H, Biebl A, Köfeler H, Plecko B.   +10 more
europepmc   +1 more source

Dysregulated balance of D- and L-amino acids modulating glutamatergic neurotransmission in severe spinal muscular atrophy. [PDF]

Neurobiol Dis
Hassan A, di Vito R, Nuzzo T, Vidali M, Carlini MJ, Yadav S, Yang H, D'Amico A, Kolici X, Valsecchi V, Panicucci C, Pignataro G, Bruno C, Bertini E, Errico F, Pellizzoni L, Usiello A.   +16 more
europepmc   +1 more source

Nusinersen and spinal muscular atrophies: Where are we in 2020?

Annals of Indian Academy of Neurology, 2020
Rakesh K. Singh, Satish V Khadilkar
openaire   +4 more sources

Long-Term Dynamics of CSF and Serum Neurofilament Light Chain in Adult Patients With 5q Spinal Muscular Atrophy Treated With Nusinersen. [PDF]

Neurology
Cordts I, Fuetterer C, Wachinger A, von Heynitz R, Kessler T, Freigang M, Quinten AL, Bjelica B, Brakemeier S, Hobbiebrunken E, Hagenacker T, Petri S, Koch JC, Hahn A, Lingor P, Deschauer M, Günther R, Weiler M, Haller B, Feneberg E.   +19 more
europepmc   +1 more source